Abstract
Cancer markers are products of cancer cells that reflect both the less differentiated state of cancer cells from normal (oncodevelopmental markers) and the molecular changes in cancer cells that take place because of activation of cell division or inhibition of the process of programmed cell death (apoptosis). The expression of these markers by cancer cells may be used to identify them as abnormal and as an indication of their malignant potential. Thus, the study of cancer markers may contribute not only to the basic understanding of the process of carcinogenesis and the biology of cancer, but also to the diagnosis and evaluation of the prognosis of patients with cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bloom H. J. G. and W. W. Richardson (1957), Br. J. Cancer 2, 359–377.
Burke, H. B. and D. E. Hensen (1993), Cancer 72, 3131–3135
Carter, C. L., C. Allen, and D. E. Hensen (1989), Cancer 63, 181–187.
Chen D. W. and S. Sell. (1994), Tumor markers, in Tietz Textbook of Clinical Chemistry. C. A. Burtis and E. R. Ashwood, eds. 2nd ed. pp. 897–927.
Clark, G. M. and W. L. McGuire (1991), Cancer Res. 51, 944–948.
Cohen, C., T. Moghazy, D. Sgoutas, and P. D. DeRose (1994), Appl. Immunohistochem. 2, 9–14.
Domagala, W., G. Striker, and A. Szadowska (1992), Am. J. Pathol. 141, 1003–1012.
Donehower, L. A. and A. Bradley (1993), Biochim. Biophys. Acta 1155, 181–205.
Duffy, M. J. (1993), Clin. Biochem. 26, 439–447.
Elston, C. W. and I. O. Ellis (1991), Histopathology 19, 403–410.
Escot C., C. Theillet, R. Lideriau, et al. (1986), Proc. Natl. Acad. Sci. USA 83, 4834–4838.
Eskelinen, M. J., P. K. Lipponen, Y. Collan, and K. J. Syrjanen (1991), Eur. J. Cancer 27, 830–834.
Field, J. K. and D. A. Spandidos (1990), Anticancer Res. 10, 1–22.
Fisher, E. R., C. Redmond, and B. Fisher (1980), Pathol. Annu. 15, 239–251.
Gasparini, G., F. Pozza, and A. L. Harris (1992), J. Natl. Cancer Inst. 85, 1206–1219.
Harris, C. C. and M. Hollstein (1993), N. Eng. J. Med. 329, 1318–1327.
Humphrey, P. A., D. W. Franquemont, W. A. Geary, et al. (1994), Appl. Immunohistochem. 2, 22–28.
Hurlimann, J. (1993), Path. Res. Pract. 189, 996–1003.
Kandalaft, P. L., K. L. Chang, C. W. Ahn, et al. (1993), Cancer 71, 2756–2763.
Kramer, B. S. et al. (1993), Ann. Int. Med. 119, 914–923.
Logue, L. J. (1993), Clin. Chem. 39, 2435–2438.
Lonn, U., S. Lonn, B. Nilsson, and B. Stenkvist (1994), Breast Cancer Res. Treatment 29, 237–245.
Mettlin, C. (1993), Cancer 72, 1050–1055.
Miki, Y, J. Swensen, S. Shattuck-Eidens, et al. (1994), Science 266, 66–71.
Miller, W. R., R. A. Elton, J. M. Dixon, U. Chetty, and D. M. A. Watson (1990), Br. J. Cancer 61, 263–266.
National Cancer Institute Consensus Dev. Confer. Statement on Treatment of Early Stage Breast Cancer (1990), NIH 8(6).
Nekulova, M., M. Simickova, L. Pecen, K. Eben, I. Vermousek, P. Stratil, M. Cernoch, and B. Lang (1994), Neoplasma 41, 113–118.
Ogura S., S. Abe, N. Sukoh, et al. (1992), Cancer 70, 63–68.
Owen, N. C. (1992), New cancer products in Serological Cancer Markers. S. Sell, ed. Humana, Totowa, NJ. pp. 495–523.
Sahin, A. A. and N. Sneige (1993) Cancer Bull. 45, 495–499.
Schwartz, G. F., R. Schwarting, P. Rabindranauth, and G. C. Finkel (1993), Clin. Chem. 39, 2404–2412.
Schwartz, M. K. (1993), Clin. Chem. 39, 2397–2403.
Sell, S. and R. Reisfeld (eds.) (1985), Monoclonal Antibodies in Cancer. Humana, Totowa, NJ.
Sell, S. and B. Wahren (eds.) (1982), Human Cancer Markers, Humana, Totowa, NJ. Sell, S. (ed.) (1992), Serological Cancer Markers. Humana, Totowa, NJ.
Sell, S. (1993), Crit. Revs. Oncogenesis 4, 419–433.
Sell, S. (ed.) (1980), Cancer Markers: Diagnostic and Developmental Significance. Humana, Totowa, NJ.
Sidransky D, T. Tokino, S. R. Hamilton, et al. (1992), Science 256, 102–105.
Sigurdsson, N., B. Baldetorp, A. Borg, et al. (1990), N. Eng. J. Med. 322, 1045–1053.
Stenmark-Askmalm, M. O. Stal, S. Sullivan, et al. (1994), Eur. J. Cancer 30A, 175–180.
Stoschek, C. M. and L. E. King (1986), Cancer Res. 46, 1030–1037.
Thor, A. D., D. H. Moore, S. M. Edgerton, et al. (1992), J. Natl. Cancer Inst. 84, 845–855.
Yu, H, E. P. Diamandis, and D. J. A. Sutherland (1994), Clin. Biochem. 27, 75–79.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sell, S., Garrett, C.T. (1995). Clinical Application of Genetic, Oncogenic, and Differentiation Markers of Cancer. In: Garrett, C.T., Sell, S. (eds) Cellular Cancer Markers. Contemporary Biomedicine, vol 12. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4757-2381-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2381-6_1
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-000-7
Online ISBN: 978-1-4757-2381-6
eBook Packages: Springer Book Archive